1. Home
  2. Analysis
  3. Valacyclovir
  4. Leukocytoclastic-vasculitis

Valacyclovir and Leukocytoclastic vasculitis - a phase IV clinical study of FDA data

Summary:

Leukocytoclastic vasculitis is reported as a side effect among people who take Valacyclovir (valacyclovir hydrochloride), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Bactrim Ds, and have Chronic lymphocytic leukaemia.

The phase IV clinical study analyzes which people have Leukocytoclastic vasculitis when taking Valacyclovir. It is created by eHealthMe based on reports of 41,259 people who have side effects when taking Valacyclovir from the FDA, and is updated regularly.

What is Valacyclovir?

Valacyclovir has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 42,107 Valacyclovir users. Check the latest studies of Valacyclovir.

What is Leukocytoclastic vasculitis?

Leukocytoclastic vasculitis (inflammation of small blood vessels (usually post-capillary venules in the dermis), characterized by palpable purpura) is found to be associated with 307 drugs and 675 conditions by eHealthMe. Check the latest studies of Leukocytoclastic vasculitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

41,259 people reported to have side effects when taking Valacyclovir.
Among them, 13 people (0.03%) have Leukocytoclastic vasculitis.

Could Valacyclovir cause Leukocytoclastic vasculitis?

Among these 13 people:

How long have people been on Valacyclovir when they have Leukocytoclastic vasculitis? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Leukocytoclastic vasculitis when taking Valacyclovir? *

  • female: 23.08 %
  • male: 76.92 %

What is the age of people who have Leukocytoclastic vasculitis when taking Valacyclovir? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 76.92 %
  • 60+: 23.08 %

What are other drugs people take besides Valacyclovir? *

  1. Bactrim Ds: 13 people, 100.00%
  2. Acetaminophen: 10 people, 76.92%
  3. Acyclovir: 10 people, 76.92%
  4. Nexium: 10 people, 76.92%
  5. Campath: 10 people, 76.92%
  6. Dapsone: 10 people, 76.92%
  7. Kenalog: 10 people, 76.92%
  8. Vicodin: 10 people, 76.92%
  9. Acetaminophen And Hydrocodone Bitartrate: 9 people, 69.23%
  10. Sulfamethoxazole And Trimethoprim: 9 people, 69.23%

What are other side effects people have besides Leukocytoclastic vasculitis? *

  1. Venous Thrombosis Limb (blood clot that forms in a vein in the limb): 10 people, 76.92%
  2. Dermatitis Psoriasiform (large white or silver flakes on the skin): 3 people, 23.08%
  3. Venous Insufficiency (poor circulation of blood caused by damaged or enlarged veins): 1 person, 7.69%

What are the existing conditions these people have? *

  1. Pain: 10 people, 76.92%
  2. Fever: 10 people, 76.92%
  3. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 10 people, 76.92%
  4. Multiple Myeloma (cancer of the plasma cells): 3 people, 23.08%
  5. Anaemia (lack of blood): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Valacyclovir and have Leukocytoclastic vasculitis?

- Check whether Leukocytoclastic vasculitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Valacyclovir:

Leukocytoclastic vasculitis treatments and more:

How severe was Leukocytoclastic vasculitis and when was it recovered:

Expand to all the drugs that have ingredients of valacyclovir hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Leukocytoclastic vasculitis:

Browse all the conditions that are associated with Leukocytoclastic vasculitis:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on valacyclovir hydrochloride (the active ingredients of Valacyclovir) and Valacyclovir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.